Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease

NCT04759365 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
25
Enrollment
INDUSTRY
Sponsor class

Stopped Delays with sites, identifying/enrolling patients, impact of COVID, staffing, and duration

Conditions

Interventions

Sponsor

Asceneuron Pty Ltd.

Collaborators